Cantitate/Preț
Produs
Total produse
Vezi coșul
Nanoparticle-Based Approaches to Targeting Drugs for Severe Diseases de Dr. Jose L. Arias

Nanoparticle-Based Approaches to Targeting Drugs for Severe Diseases: Woodhead Publishing Series in Biomedicine

Autor Dr. Jose L. Arias
en Limba Engleză Hardback – 31 dec 2019
Nanoparticle-based approaches to targeting drugs for severe diseases is devoted to the analysis of the latest developments in the use of passive and/or active targeting nano-strategies for controlling the biodistribution profiles of pharmacotherapy agents.
Citește tot Restrânge

Din seria Woodhead Publishing Series in Biomedicine

Preț: 81378 lei

Preț vechi: 99242 lei
-18% Nou

Puncte Express: 1221
Preț estimativ în valută:
15576€ • 16234$ • 12966£

Carte indisponibilă temporar


Wish list
Gift list
Am citit!
Adaugă în listă
Doresc să fiu notificat când acest titlu va fi disponibil:
Trimite
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781907568114
ISBN-10: 1907568115
Pagini: 300
Dimensiuni: 156 x 234 mm
Greutate: 0 kg
Editura: Woodhead Publishing
Seria Woodhead Publishing Series in Biomedicine

Notă biografică

Dr Jose L. Arias is an assistant professor of Pharmaceutical Technology, Clinical Pharmacy, and Drug Delivery, as well as Biopharmacy and Pharmacokinetics, at the Department of Pharmacy and Pharmaceutical Technology in the University of Granada, Spain. He has also worked as Associate Researcher of UMR CNRS 8612 'Physico-chimie, Pharmacotechnie et Biopharmacie' at the Universite Paris-Sud, France. His research group is actively involved in the development of colloidal drug delivery systems against severe diseases (cancer, autoimmune diseases, infectious diseases, etc.). His area of specialization includes a focus on the formulation of advanced drug nanocarriers on the basis of passive and active targeting strategies. More recently, he has commenced work on engineering strategies for the preparation of theragnostic nanoparticles.

Cuprins

Integration of nanotechnology in pharmacotherapy; Nanostructures in drug delivery; Nano-engineering strategies for passive drug delivery and targeting; Nano-engineering strategies for ligand-mediated drug delivery and targeting; Nano-engineering strategies for stimuli-sensitive drug delivery and targeting; Nano-engineering strategies in theragnosis; Advanced nanomedicines against severe diseases.